Literature DB >> 7549268

Increased plasma levels of soluble thrombomodulin in patients with sepsis and organ failure.

T Iba1, Y Yagi, A Kidokoro, M Fukunaga, T Fukunaga.   

Abstract

The fact that thrombomodulin (TM) is released into the bloodstream from damaged vascular endothelial cells led us to hypothesize that plasma levels of soluble TM could be an indicator of the development of organ failure. In this study, we examined the changes in plasma levels of TM in 60 septic patients and 13 postsurgical patients, and investigated the circulating levels of interleukin 6 (IL-6) and polymorphonuclear leukocyte elastase (PMN-E) to determine the mechanism causing the excess liberation of TM. The arterial ketone body ratio (AKBR) was also measured as an indicator of the hepatocyte energy state. Of the 60 septic patients, 26 developed organ failure, 10 of whom died. In contrast, none of the postsurgical patients developed organ failure. The mean plasma level of TM was significantly higher in the septic patients who developed organ failure compared to those without organ failure (P < 0.001) or the postsurgical patients (P < 0.001). Furthermore, those patients whose plasma TM values became elevated over 6.0 ng/ml frequently developed complications. A positive correlation was also observed between the plasma TM levels and the IL-6 (P < 0.01) and PMN-E levels (P < 0.01). In contrast, a negative correlation was seen between the plasma TM levels and the AKBR (P < 0.01). These findings show that plasma TM could be a useful indicator of impending organ failure during sepsis.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7549268     DOI: 10.1007/bf00311430

Source DB:  PubMed          Journal:  Surg Today        ISSN: 0941-1291            Impact factor:   2.549


  24 in total

1.  The influence of hemodilution in normal and cirrhotic rats in relation to hepatic energy metabolism.

Authors:  A Tanaka; T Morimoto; Y Taki; M Noguchi; T Nakatani; Y Kamiyama; Y Yamaoka; K Ozawa
Journal:  Am J Med Sci       Date:  1987-11       Impact factor: 2.378

2.  [Clinical application of laboratory diagnosis: leukemia and DIC].

Authors:  K Deguchi; L J Zhao; S Shirakawa
Journal:  Rinsho Byori       Date:  1991-07

3.  Tolerance of the liver as measured by ketone body ratio and hepatocyte energy charge to 120 minutes acute venous congestion in dogs.

Authors:  H Higashiyama; M Yamaguchi; K Kumada; H Sasaki; T Yamaguchi; K Ozawa
Journal:  Circ Shock       Date:  1992-11

4.  Plasma thrombomodulin in health and diseases.

Authors:  S Takano; S Kimura; S Ohdama; N Aoki
Journal:  Blood       Date:  1990-11-15       Impact factor: 22.113

5.  Tumor necrosis factor and interleukin 1 appearance in experimental gram-negative septic shock. The effects of plasma exchange with albumin and plasma infusion.

Authors:  R Busund; R O Lindsetmo; L T Rasmussen; O Røkke; O P Rekvig; A Revhaug
Journal:  Arch Surg       Date:  1991-05

6.  Association between tumour necrosis factor in serum and fatal outcome in patients with meningococcal disease.

Authors:  A Waage; A Halstensen; T Espevik
Journal:  Lancet       Date:  1987-02-14       Impact factor: 79.321

7.  The turnover of thrombin-thrombomodulin complex in cultured human umbilical vein endothelial cells and A549 lung cancer cells. Endocytosis and degradation of thrombin.

Authors:  I Maruyama; P W Majerus
Journal:  J Biol Chem       Date:  1985-12-15       Impact factor: 5.157

8.  Cytokine appearance in human endotoxemia and primate bacteremia.

Authors:  D G Hesse; K J Tracey; Y Fong; K R Manogue; M A Palladino; A Cerami; G T Shires; S F Lowry
Journal:  Surg Gynecol Obstet       Date:  1988-02

9.  Monoclonal antibodies for human thrombomodulin which recognize binding sites for thrombin and protein C.

Authors:  T Hayashi; K Suzuki
Journal:  J Biochem       Date:  1990-11       Impact factor: 3.387

10.  One-step sandwich enzyme immunoassay for soluble human thrombomodulin using monoclonal antibodies.

Authors:  S Kodama; E Uchijima; M Nagai; K Mikawatani; T Hayashi; K Suzuki
Journal:  Clin Chim Acta       Date:  1990-12-03       Impact factor: 3.786

View more
  11 in total

1.  Carbohydrate-binding protein CLEC14A regulates VEGFR-2- and VEGFR-3-dependent signals during angiogenesis and lymphangiogenesis.

Authors:  Sungwoon Lee; Seung-Sik Rho; Hyojin Park; Jeong Ae Park; Jihye Kim; In-Kyu Lee; Gou Young Koh; Naoki Mochizuki; Young-Myeong Kim; Young-Guen Kwon
Journal:  J Clin Invest       Date:  2016-12-19       Impact factor: 14.808

Review 2.  Therapeutic modulation of coagulation and fibrinolysis in acute lung injury and the acute respiratory distress syndrome.

Authors:  Sara C Sebag; Julie A Bastarache; Lorraine B Ware
Journal:  Curr Pharm Biotechnol       Date:  2011-09       Impact factor: 2.837

3.  Novel role of the human alveolar epithelium in regulating intra-alveolar coagulation.

Authors:  Ling Wang; Julie A Bastarache; Nancy Wickersham; Xiaohui Fang; Michael A Matthay; Lorraine B Ware
Journal:  Am J Respir Cell Mol Biol       Date:  2006-11-10       Impact factor: 6.914

4.  Recombinant thrombomodulin domain 1 rescues pathological angiogenesis by inhibition of HIF-1α-VEGF pathway.

Authors:  Yi-Hsun Huang; Cheng-Hsiang Kuo; I-Chen Peng; Yi-Sheng Chang; Sung-Huei Tseng; Edward M Conway; Hua-Lin Wu
Journal:  Cell Mol Life Sci       Date:  2021-10-27       Impact factor: 9.261

Review 5.  Circulating Thrombomodulin: Release Mechanisms, Measurements, and Levels in Diseases and Medical Procedures.

Authors:  Mallorie Boron; Tiffany Hauzer-Martin; Joseph Keil; Xue-Long Sun
Journal:  TH Open       Date:  2022-07-11

6.  Significance of endothelial molecular markers in the evaluation of the severity of acute pancreatitis.

Authors:  Satoshi Ida; Yoshinori Fujimura; Masahiko Hirota; Yu Imamura; Nobuyuki Ozaki; Koichi Suyama; Daisuke Hashimoto; Masaki Ohmuraya; Hiroshi Tanaka; Hiroshi Takamori; Hideo Baba
Journal:  Surg Today       Date:  2009-03-25       Impact factor: 2.549

7.  Aging exacerbates microvascular endothelial damage induced by circulating factors present in the serum of septic patients.

Authors:  Zsuzsanna Tucsek; Tripti Gautam; William E Sonntag; Peter Toth; Hiroshi Saito; Reinaldo Salomao; Csaba Szabo; Anna Csiszar; Zoltan Ungvari
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2012-11-26       Impact factor: 6.053

8.  Increased serum thrombomodulin level is associated with disease severity and mortality in pediatric sepsis.

Authors:  Jainn-Jim Lin; Hsiang-Ju Hsiao; Oi-Wa Chan; Yu Wang; Shao-Hsuan Hsia; Cheng-Hsun Chiu
Journal:  PLoS One       Date:  2017-08-03       Impact factor: 3.240

9.  Markers of acute kidney injury in patients with sepsis: the role of soluble thrombomodulin.

Authors:  Shinshu Katayama; Shin Nunomiya; Kansuke Koyama; Masahiko Wada; Toshitaka Koinuma; Yuya Goto; Ken Tonai; Jun Shima
Journal:  Crit Care       Date:  2017-08-25       Impact factor: 9.097

10.  Thrombomodulin, Plasminogen Activator Inhibitor-1 and Protein C Levels, and Organ Dysfunction in Sepsis.

Authors:  Shinshu Katayama; Kansuke Koyama; Jun Shima; Ken Tonai; Yuya Goto; Toshitaka Koinuma; Shin Nunomiya
Journal:  Crit Care Explor       Date:  2019-05-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.